Gastroenterology News and Research

RSS

Gastroenterology is the branch of medicine where the digestive system and its disorders are studied.

Alcohol relapse adversely affects liver transplant survival

A new study on how alcohol relapse affects survival rates after liver transplants found that it adversely affected survival rates only after 10 years. The decrease in survival rates may, however, be due to other alcohol-related diseases.

22 Mar 2005

Cetrorelix progresses to full development for the treatment of Endometriosis in women

Solvay Pharmaceuticals has decided to undertake full Phase III development with cetrorelix for the treatment of endometriosis in women.

16 Mar 2005

Important advance in our understanding of colorectal cancer

An international team of medical scientists has made an important advance in our understanding of the second most fatal form of cancer in the industrialized world. Professor Jeremy R. Jass, who holds a Canada Research Chair in Gastrointestinal Pathology at McGill University in Montreal

3 Mar 2005

Self-reporting of symptoms by patients with ulcerative colitis better than assessing patients with endoscopy

People living with fatigue, abdominal discomfort and bloody diarrhea caused by the chronic inflammation of ulcerative colitis may no longer need to undergo frequent and uncomfortable endoscopies, a new study shows.

27 Feb 2005

Suffering from fatigue, abdominal discomfort or bloody diarrhea? Your doctor might not recommend an uncomfortable endoscopy

3 Feb 2005

Calcium and vitamin D treatment alone can improve bone mineral density in Crohn's patients

According to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, the addition of popular bone building drugs to calcium and vitamin D therapy to treat bone loss associated with Crohn's disease is not beneficial.

1 Feb 2005

VCU Gastroenterology research papers ranked 4th in most cited papers

Virginia Commonwealth University’s School of Medicine has been ranked fourth among federally funded U.S. universities based on the average number of citations per research paper published in indexed journals of gastroenterology and hepatology between 1999 and 2003.

26 Jan 2005

Biochip for detection of inflammatory bowel disease

At the III International Symposium on Advanced Therapy for Chronic Inflammatory Bowel Disease, held in Madrid, the biotechnological company, Progenika, presented a DNA-chip the purpose of which is the optimisation of the diagnosis, prognosis and treatment of patients with inflammatory bowel disease (Crohn’s disease and Ulcerous Colitis).

26 Jan 2005

By age six, children of overweight mothers are fifteen times more likely to be obese

By age six, children of overweight mothers are fifteen times more likely to be obese than children of lean mothers. The research, at The Children's Hospital of Philadelphia and the University of Pennsylvania, showed the strength of genetic influences, and suggests that efforts to prevent obesity should focus on such children at risk, preferably by four years of age.

25 Jan 2005

Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestine

According to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, chronic users of non-steroidal anti-inflammatory drugs (NSAIDs) have an increased risk of bleeding and visible damage to their small intestine.

4 Jan 2005

Chronic constipation is uncomfortable, but not dangerous

There are a lot of common myths about constipation treatment. An article in the January issue of The American Journal of Gastroenterology dispels those myths and clears numerous misconceptions regarding chronic constipation.

4 Jan 2005

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.

14 Nov 2004

Abbott's investigational anti-interleukin-12 fully human monoclonal antibody in Crohn's disease study

Results of a Phase II study of Abbott's ABT-874, a fully human anti-interleukin-12 (IL-12) monoclonal antibody, will appear tomorrow in the New England Journal of Medicine citing treatment with ABT-874 shows differences in response and remission in patients with active Crohn's disease compared to placebo, in one arm of the study.

10 Nov 2004

Treatment to control gastroesophageal reflux disease in children found to be ineffective

According to a study published in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, more than 60 percent of the children who received surgical fundoplication to control gastroesophageal reflux disease (GERD) had recurring symptoms of the disease months following surgery.

4 Nov 2004

New treatment option for patients who have moderately active ulcerative colitis

Results of a study presented today by a Mayo Clinic physician at the 69th Annual Scientific Meeting of the American College of Gastroenterology (ACG) in Orlando, Fla., offer a new treatment option for patients who have moderately active ulcerative colitis.

1 Nov 2004

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Interim study results indicate a certain drug combination treatment may suppress the hepatitis C virus more quickly than another.

1 Nov 2004

Symptoms of heartburn and GERD are highly prevalent among obese patients

Overall, heartburn and or acid regurgitation were found among 75 percent of the morbidly obese patients, while 23 percent experienced difficulty swallowing (dysphagia) and 34 percent experienced asthma symptoms.

1 Nov 2004

Infants born to women with Inflammatory Bowel Disease (IBD), no more likely to develop congenital malformations

Infants born to women with Inflammatory Bowel Disease (IBD) are no more likely to develop congenital malformations than infants born to healthy mothers, according to a study presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology.

1 Nov 2004

New therapy under development for the treatment of irritable bowel syndrome

A new therapy under development for the treatment of irritable bowel syndrome with diarrhea predominance appears to provide significant improvements in measures of quality of life, according to a study presented at the 69th Annual Meeting of the American College of Gastroenterology.

1 Nov 2004

Patients are receiving initial diagnosis of celiac disease at an older age

Patients are receiving initial diagnosis of celiac disease at an older age and with a shorter duration of symptoms, according to a retrospective study presented today at the 69th Annual Scientific Meeting of the American College of Gastroenterology.

1 Nov 2004

Gastroenterology News and Research

Further Reading

Alcohol relapse adversely affects liver transplant survival

Cetrorelix progresses to full development for the treatment of Endometriosis in women

Important advance in our understanding of colorectal cancer

Self-reporting of symptoms by patients with ulcerative colitis better than assessing patients with endoscopy

Suffering from fatigue, abdominal discomfort or bloody diarrhea? Your doctor might not recommend an uncomfortable endoscopy

Calcium and vitamin D treatment alone can improve bone mineral density in Crohn's patients

VCU Gastroenterology research papers ranked 4th in most cited papers

Biochip for detection of inflammatory bowel disease

By age six, children of overweight mothers are fifteen times more likely to be obese

Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestine

Chronic constipation is uncomfortable, but not dangerous

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

Abbott's investigational anti-interleukin-12 fully human monoclonal antibody in Crohn's disease study

Treatment to control gastroesophageal reflux disease in children found to be ineffective

New treatment option for patients who have moderately active ulcerative colitis

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Symptoms of heartburn and GERD are highly prevalent among obese patients

Infants born to women with Inflammatory Bowel Disease (IBD), no more likely to develop congenital malformations

New therapy under development for the treatment of irritable bowel syndrome

Patients are receiving initial diagnosis of celiac disease at an older age

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News